ScPharmaceuticals Receives 5 Patent Allowances for Furosemide Formulation

MT Newswires Live

Aug 14, 2025

ScPharmaceuticals (SCPH) said Thursday it received five notices of allowance from the US Patent and Trademark Office for patent applications covering its SCP-111 furosemide formulation.

A notice of allowance informs the applicant that the patent or trademark application has been approved and is ready for the next steps towards registration, according to the USPTO.

ScPharmaceuticals said the patents, once granted, will add to the four existing patents related to SCP-111.

The company said it plans to file a supplemental new drug application for the formulation in the current quarter.

ScPharmaceuticals shares were up 2.9% in recent premarket activity Thursday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2559950895"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2559950895\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2559950895?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-14 21:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2559950895","market":"fut","top_or_hot":-1,"title":"ScPharmaceuticals Receives 5 Patent Allowances for Furosemide Formulation","media":"MT Newswires Live","content":"<html><body><p> ScPharmaceuticals (SCPH) said Thursday it received five notices of allowance from the US Patent and Trademark Office for patent applications covering its SCP-111 furosemide formulation.</p><p>A notice of allowance informs the applicant that the patent or trademark application has been approved and is ready for the next steps towards registration, according to the USPTO.</p><p>ScPharmaceuticals said the patents, once granted, will add to the four existing patents related to SCP-111.</p><p>The company said it plans to file a supplemental new drug application for the formulation in the current quarter.</p><p>ScPharmaceuticals shares were up 2.9% in recent premarket activity Thursday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ScPharmaceuticals Receives 5 Patent Allowances for Furosemide Formulation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nScPharmaceuticals Receives 5 Patent Allowances for Furosemide Formulation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-08-14 21:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> ScPharmaceuticals (SCPH) said Thursday it received five notices of allowance from the US Patent and Trademark Office for patent applications covering its SCP-111 furosemide formulation.</p><p>A notice of allowance informs the applicant that the patent or trademark application has been approved and is ready for the next steps towards registration, according to the USPTO.</p><p>ScPharmaceuticals said the patents, once granted, will add to the four existing patents related to SCP-111.</p><p>The company said it plans to file a supplemental new drug application for the formulation in the current quarter.</p><p>ScPharmaceuticals shares were up 2.9% in recent premarket activity Thursday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SCPH","symbol_name":"Scpharmaceuticals Inc.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2559950895","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2559950895","pubTimestamp":1755177495,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"ScPharmaceuticals (SCPH) said Thursday it received five notices of allowance from the US Patent and Trademark Office for patent applications covering its SCP-111 furosemide formulation.A notice of all","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SCPH":"Scpharmaceuticals Inc.","BK4007":"制药"},"translate_title":"ScPharmaceuticals获得呋塞米制剂5项专利授权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SCPH":0.9},"content_text":"ScPharmaceuticals (SCPH) said Thursday it received five notices of allowance from the US Patent and Trademark Office for patent applications covering its SCP-111 furosemide formulation.A notice of allowance informs the applicant that the patent or trademark application has been approved and is ready for the next steps towards registration, according to the USPTO.ScPharmaceuticals said the patents, once granted, will add to the four existing patents related to SCP-111.The company said it plans to file a supplemental new drug application for the formulation in the current quarter.ScPharmaceuticals shares were up 2.9% in recent premarket activity Thursday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}